MUMBAI, India, Feb. 27 -- Intellectual Property India has published a patent application (202611005853 A) filed by Suresh Gyan Vihar University, Jaipur, Rajasthan, on Jan. 20, for 'an injectable nanoparticle suspension for targeted anticancer drug delivery therapy application.'
Inventor(s) include Dr. Ritu M Gilhotra; and Dr. Gaurav Sharma.
The application for the patent was published on Feb. 27, under issue no. 09/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to an injectable nanoparticle suspension (100) for targeted anticancer drug delivery. The suspension comprises biocompatible nanoparticles (110) encapsulating an anticancer drug (112) within a core matrix (111) and dispersed in an aqueous carrier medium (120). The nanoparticles may include a stabilizing shell (113) and surface modification layer (114) with targeting ligands (115) for enhanced tumor specificity. The invention enables controlled drug release, improved therapeutic efficacy, reduced systemic toxicity, and enhanced patient outcomes."
Disclaimer: Curated by HT Syndication.
